WO2003101428A1 - Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung, verfahren zu derer zubereitung - Google Patents
Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung, verfahren zu derer zubereitung Download PDFInfo
- Publication number
- WO2003101428A1 WO2003101428A1 PCT/EP2003/005115 EP0305115W WO03101428A1 WO 2003101428 A1 WO2003101428 A1 WO 2003101428A1 EP 0305115 W EP0305115 W EP 0305115W WO 03101428 A1 WO03101428 A1 WO 03101428A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mixture
- active ingredient
- pharmaceutical composition
- rollers
- active substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/516,268 US20050202088A1 (en) | 2002-05-31 | 2003-05-15 | Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
DK03735396T DK1509205T3 (da) | 2002-05-31 | 2003-05-15 | Farmaceutisk sammensætning med forsinket frisætning af aktivt stof og fremgangsmåde til fremstilling heraf |
JP2004508786A JP2005528428A (ja) | 2002-05-31 | 2003-05-15 | 活性物質の遅延放出を有する薬学的組成物およびこれらの調製方法 |
BR0311512-7A BR0311512A (pt) | 2002-05-31 | 2003-05-15 | Composição farmacêiutica com liberação retardada de substância ativa, processo para sua preparação |
EP03735396A EP1509205B1 (de) | 2002-05-31 | 2003-05-15 | Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung und verfahren zu deren zubereitung |
CA002485080A CA2485080A1 (en) | 2002-05-31 | 2003-05-15 | Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
DE50310366T DE50310366D1 (de) | 2002-05-31 | 2003-05-15 | Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung und verfahren zu deren zubereitung |
AU2003236658A AU2003236658A1 (en) | 2002-05-31 | 2003-05-15 | Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
MXPA04011813A MXPA04011813A (es) | 2002-05-31 | 2003-05-15 | Composicion farmaceutica con liberacion retardada de la substancia activa, y procedimiento para su preparacion. |
NO20045386A NO20045386L (no) | 2002-05-31 | 2004-12-09 | Farmasoytisk preparat med forsinket frigivelse av aktivt stoff og fremgangsmate for fremstilling derav |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10224170A DE10224170A1 (de) | 2002-05-31 | 2002-05-31 | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
DE10224170.8 | 2002-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003101428A1 true WO2003101428A1 (de) | 2003-12-11 |
Family
ID=29432488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/005115 WO2003101428A1 (de) | 2002-05-31 | 2003-05-15 | Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung, verfahren zu derer zubereitung |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050202088A1 (de) |
EP (1) | EP1509205B1 (de) |
JP (1) | JP2005528428A (de) |
AT (1) | ATE405252T1 (de) |
AU (1) | AU2003236658A1 (de) |
BR (1) | BR0311512A (de) |
CA (1) | CA2485080A1 (de) |
DE (2) | DE10224170A1 (de) |
DK (1) | DK1509205T3 (de) |
ES (1) | ES2312792T3 (de) |
MX (1) | MXPA04011813A (de) |
NO (1) | NO20045386L (de) |
PL (1) | PL374041A1 (de) |
WO (1) | WO2003101428A1 (de) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006080029A1 (en) * | 2005-01-27 | 2006-08-03 | Alembic Limited | Extended release formulation of levetiracetam |
WO2006123357A2 (en) | 2005-02-22 | 2006-11-23 | Sun Pharmaceutical Industries Limited | Oral controlled release composition containing levetiracetam |
WO2007130478A2 (en) * | 2006-05-04 | 2007-11-15 | Novartis Ag | Heated roller compaction process for making pharmaceutical compositions |
EP1871363A1 (de) * | 2005-03-30 | 2008-01-02 | Genpharm Inc. | Kombinierter stufenprozess für pharmazeutische zusammensetzungen |
WO2008006528A3 (en) * | 2006-07-13 | 2008-04-10 | Ucb Pharma Sa | Pharmaceutical compositions comprising levetiracetam |
WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
EP1931759A2 (de) * | 2005-09-14 | 2008-06-18 | Isp Investments Inc. | Verfahren und vorrichtung zur herstellung von agglomeraten aus einer pulverförmigen zusammensetzung aus wirkstoff und bindemittel |
JP2008520736A (ja) * | 2004-11-23 | 2008-06-19 | アマダス ファーマシューティカルズ インコーポレイテッド | 持続放出コーティングまたはマトリックスおよびnmda受容体アンタゴニストを含む組成物、そのようなnmdaアンタゴニストの被験体への投与方法 |
EP2298290A1 (de) | 2009-09-16 | 2011-03-23 | LEK Pharmaceuticals d.d. | Zusammensetzung mit Levetiracetam zur gesteuerten Abgabe |
US8575172B2 (en) | 2006-09-26 | 2013-11-05 | Zysis Limited | Pharmaceutical compositions of aripiprazole |
US9763954B2 (en) | 2007-01-15 | 2017-09-19 | Bial—Portela & Ca, S.A. | Therapeutical uses of eslicarbazepine |
US10675287B2 (en) | 2005-05-06 | 2020-06-09 | Bial-Portela & Ca S.A. | Methods of treatment of partial onset seizures using eslicarbazepine acetate |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL213565B1 (pl) * | 2002-07-29 | 2013-03-29 | Glaxo Group Ltd | Preparat o przedluzonym uwalnianiu zawierajacy lamotrygine |
EP1753398B1 (de) * | 2004-06-10 | 2018-09-19 | Glatt Air Techniques, Inc. | Pharmazeutische darreichungsformulierung mit kontrollierter freisetzungsmatrix |
CA2592605C (en) | 2004-12-27 | 2010-12-07 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
ATE429906T1 (de) * | 2006-01-05 | 2009-05-15 | Teva Pharma | Trockene aripiprazolformulierungen |
ES2318693T5 (es) * | 2006-01-05 | 2018-10-04 | Teva Pharmaceutical Industries Ltd | Procedimiento de granulación en húmedo para la preparación de composiciones farmacéuticas de aripiprazol |
EP2359830B1 (de) | 2006-04-26 | 2012-09-19 | Supernus Pharmaceuticals, Inc. | Oxcarbazepinpräparate für kontrollierte Freisetzung mit sigmoidalem Freisetzungsprofil |
FI20060501L (fi) * | 2006-05-22 | 2007-11-23 | Biohit Oyj | Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa |
US7878430B2 (en) * | 2006-11-20 | 2011-02-01 | The University Of Western Ontario | Method and apparatus for uniformly dispersing additive particles in fine powders |
US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
US20110313037A1 (en) * | 2008-12-20 | 2011-12-22 | Saakian Susanna A | [2.2.2] Bicyclic Derivatives and Methods of Use |
CA2759807C (en) * | 2009-04-23 | 2018-03-20 | Sustained Nano Systems Llc | Controlled release dispensing device |
CA2782556C (en) | 2009-12-02 | 2018-03-27 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
US9333175B2 (en) * | 2010-06-16 | 2016-05-10 | Mylan Inc. | Controlled release levetiracetam formulations and methods for producing the same |
WO2014204933A1 (en) | 2013-06-17 | 2014-12-24 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB961813A (en) * | 1963-03-18 | 1964-06-24 | American Cyanamid Co | Apparatus for densifying powdered materials |
US4731122A (en) * | 1987-03-30 | 1988-03-15 | Alza Corporation | Process for manufacturing a thermoplastic molding composition |
EP0852140A1 (de) * | 1995-08-11 | 1998-07-08 | Nissan Chemical Industries, Limited | Verfahren um ein schwerlöslicher arzneistoff zu amorphisieren |
EP1201709A1 (de) * | 2000-10-24 | 2002-05-02 | Emess AG | Coprozessiertes Sprengmittelgranulat |
-
2002
- 2002-05-31 DE DE10224170A patent/DE10224170A1/de not_active Withdrawn
-
2003
- 2003-05-15 CA CA002485080A patent/CA2485080A1/en not_active Abandoned
- 2003-05-15 MX MXPA04011813A patent/MXPA04011813A/es not_active Application Discontinuation
- 2003-05-15 WO PCT/EP2003/005115 patent/WO2003101428A1/de active IP Right Grant
- 2003-05-15 AU AU2003236658A patent/AU2003236658A1/en not_active Abandoned
- 2003-05-15 DK DK03735396T patent/DK1509205T3/da active
- 2003-05-15 PL PL03374041A patent/PL374041A1/xx not_active Application Discontinuation
- 2003-05-15 ES ES03735396T patent/ES2312792T3/es not_active Expired - Lifetime
- 2003-05-15 US US10/516,268 patent/US20050202088A1/en not_active Abandoned
- 2003-05-15 BR BR0311512-7A patent/BR0311512A/pt not_active IP Right Cessation
- 2003-05-15 AT AT03735396T patent/ATE405252T1/de not_active IP Right Cessation
- 2003-05-15 JP JP2004508786A patent/JP2005528428A/ja not_active Withdrawn
- 2003-05-15 DE DE50310366T patent/DE50310366D1/de not_active Expired - Lifetime
- 2003-05-15 EP EP03735396A patent/EP1509205B1/de not_active Expired - Lifetime
-
2004
- 2004-12-09 NO NO20045386A patent/NO20045386L/no unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB961813A (en) * | 1963-03-18 | 1964-06-24 | American Cyanamid Co | Apparatus for densifying powdered materials |
US4731122A (en) * | 1987-03-30 | 1988-03-15 | Alza Corporation | Process for manufacturing a thermoplastic molding composition |
EP0852140A1 (de) * | 1995-08-11 | 1998-07-08 | Nissan Chemical Industries, Limited | Verfahren um ein schwerlöslicher arzneistoff zu amorphisieren |
EP1201709A1 (de) * | 2000-10-24 | 2002-05-02 | Emess AG | Coprozessiertes Sprengmittelgranulat |
Non-Patent Citations (1)
Title |
---|
SHESKEY P ET AL: "Roll compaction granulation of a controlled-release matrix tablet formulation containing HPMC: Effect of process scale-up on robustness of tablets, tablet stability, and predicted in vivo performance", PHARMACEUTICAL TECHNOLOGY 2000 UNITED STATES, vol. 24, no. 11, 2000, pages 30 - 52, XP002254876, ISSN: 0147-8087 * |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008520736A (ja) * | 2004-11-23 | 2008-06-19 | アマダス ファーマシューティカルズ インコーポレイテッド | 持続放出コーティングまたはマトリックスおよびnmda受容体アンタゴニストを含む組成物、そのようなnmdaアンタゴニストの被験体への投与方法 |
WO2006080029A1 (en) * | 2005-01-27 | 2006-08-03 | Alembic Limited | Extended release formulation of levetiracetam |
US7863316B2 (en) | 2005-01-27 | 2011-01-04 | Ucb Pharma S.A. | Extended release formulation of Levetiracetam |
US7858122B2 (en) | 2005-01-27 | 2010-12-28 | Ucb Pharma S.A. | Extended release formulation of levetiracetam |
EA014249B1 (ru) * | 2005-01-27 | 2010-10-29 | Алембик Лимитед | Формуляция леветирацетама длительного высвобождения |
JP2008528571A (ja) * | 2005-01-27 | 2008-07-31 | アレムビック・リミテッド | レベチラセタムの徐放性製剤 |
US8431156B2 (en) | 2005-02-22 | 2013-04-30 | Sun Pharma Advanced Research Company Ltd. | Pharmaceutical composition |
WO2006123357A2 (en) | 2005-02-22 | 2006-11-23 | Sun Pharmaceutical Industries Limited | Oral controlled release composition containing levetiracetam |
WO2006123357A3 (en) * | 2005-02-22 | 2007-09-20 | Sun Pharmaceutical Ind Ltd | Oral controlled release composition containing levetiracetam |
US8425938B2 (en) | 2005-02-22 | 2013-04-23 | Sun Pharma Advanced Research Company Ltd. | Pharmaceutical composition |
US8535717B2 (en) | 2005-02-22 | 2013-09-17 | Sun Pharma Advanced Research Company Limited | Pharmaceutical composition |
EP1871363A1 (de) * | 2005-03-30 | 2008-01-02 | Genpharm Inc. | Kombinierter stufenprozess für pharmazeutische zusammensetzungen |
JP2008534522A (ja) * | 2005-03-30 | 2008-08-28 | ジェンファーム インク | 医薬組成物のための複合ステップ製造方法 |
EP1871363A4 (de) * | 2005-03-30 | 2009-01-21 | Genpharm Inc | Kombinierter stufenprozess für pharmazeutische zusammensetzungen |
US8216611B2 (en) | 2005-03-30 | 2012-07-10 | Mylan Pharmaceuticals Ulc | Combined-step process for pharmaceutical compositions |
US10675287B2 (en) | 2005-05-06 | 2020-06-09 | Bial-Portela & Ca S.A. | Methods of treatment of partial onset seizures using eslicarbazepine acetate |
US10695354B2 (en) | 2005-05-06 | 2020-06-30 | Bial-Portela & Ca S.A. | Methods of treatment of partial onset seizures using eslicarbazepine acetate |
US10702536B2 (en) | 2005-05-06 | 2020-07-07 | Bial-Portela & Ca S.A. | Methods of treatment of partial onset seizures using eslicarbazepine acetate |
US11364247B2 (en) | 2005-05-06 | 2022-06-21 | Bial-Portela & Ca S.A. | Methods of treatment of partial onset seizures using eslicarbazepine acetate |
EP1931759A4 (de) * | 2005-09-14 | 2012-08-08 | Isp Investments Inc | Verfahren und vorrichtung zur herstellung von agglomeraten aus einer pulverförmigen zusammensetzung aus wirkstoff und bindemittel |
US7534381B2 (en) * | 2005-09-14 | 2009-05-19 | Isp Investments Inc. | Process and apparatus for forming agglomerates of a powder composition of an active and binder |
EP1931759A2 (de) * | 2005-09-14 | 2008-06-18 | Isp Investments Inc. | Verfahren und vorrichtung zur herstellung von agglomeraten aus einer pulverförmigen zusammensetzung aus wirkstoff und bindemittel |
WO2007130478A3 (en) * | 2006-05-04 | 2008-01-24 | Novartis Ag | Heated roller compaction process for making pharmaceutical compositions |
WO2007130478A2 (en) * | 2006-05-04 | 2007-11-15 | Novartis Ag | Heated roller compaction process for making pharmaceutical compositions |
WO2008006528A3 (en) * | 2006-07-13 | 2008-04-10 | Ucb Pharma Sa | Pharmaceutical compositions comprising levetiracetam |
WO2008062446A3 (en) * | 2006-09-14 | 2008-08-14 | Alembic Ltd | An extended release composition of levetiracetam, which exhibits no adverse food effect |
WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
US8575172B2 (en) | 2006-09-26 | 2013-11-05 | Zysis Limited | Pharmaceutical compositions of aripiprazole |
US9763954B2 (en) | 2007-01-15 | 2017-09-19 | Bial—Portela & Ca, S.A. | Therapeutical uses of eslicarbazepine |
WO2011033024A1 (en) | 2009-09-16 | 2011-03-24 | Lek Pharmaceuticals D.D. | Controlled release composition comprising levetiracetam |
EP2298290A1 (de) | 2009-09-16 | 2011-03-23 | LEK Pharmaceuticals d.d. | Zusammensetzung mit Levetiracetam zur gesteuerten Abgabe |
Also Published As
Publication number | Publication date |
---|---|
DE10224170A1 (de) | 2003-12-11 |
MXPA04011813A (es) | 2005-07-26 |
DK1509205T3 (da) | 2008-11-24 |
JP2005528428A (ja) | 2005-09-22 |
PL374041A1 (en) | 2005-09-19 |
EP1509205A1 (de) | 2005-03-02 |
NO20045386L (no) | 2004-12-09 |
ES2312792T3 (es) | 2009-03-01 |
EP1509205B1 (de) | 2008-08-20 |
ATE405252T1 (de) | 2008-09-15 |
CA2485080A1 (en) | 2003-12-11 |
DE50310366D1 (de) | 2008-10-02 |
BR0311512A (pt) | 2005-02-22 |
US20050202088A1 (en) | 2005-09-15 |
AU2003236658A1 (en) | 2003-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1509205B1 (de) | Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung und verfahren zu deren zubereitung | |
EP0253104B1 (de) | Trägermassen für die kontrollierte Freisetzung pharmazeutischer Wirkstoffe | |
US4970075A (en) | Controlled release bases for pharmaceuticals | |
DE69802543T3 (de) | Verbesserte multipartikel-tablette mit schnellauflösbarkeit | |
DE69535426T2 (de) | Schmelzextrudierte oral verabreichbare Opioidformulierungen | |
EP0864326B1 (de) | Mehrphasige wirkstoffhaltige Zubereitungsformen | |
DE69915718T2 (de) | Fliessfähige, direktverpressbare Stärke als Bindemittel, Sprengmittel und Füllstoff für Presstabletten und Hartgelatinkapseln | |
DE69434640T2 (de) | Heterodisperse Hydrogelsysteme zur verzögerten Freisetzung unlöslicher Arzneistoffe | |
AT391078B (de) | Verfahren zur herstellung von granulaten bzw. von presstabletten mit regulierter wirkstoffabgabe | |
EP0809488A1 (de) | Feste wirkstoff-zubereitungen | |
JP4861552B2 (ja) | シクロデキストリン含有固形剤型の製造方法 | |
DE60211183T2 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
EP1556012B1 (de) | Herstellung von festen dosierungsformen unter verwendung eines vernetzten nicht-thermoplastischen tr gers | |
JP2004527458A5 (de) | ||
EP1142571B1 (de) | Verfahren zur Herstellung von festen Kreatin-Dosierungsformen und dadurch erhältliche Dosierungsformen | |
EP1748762B1 (de) | Dosierungsform, erhältlich aus einer ein anorganisches pigment umfassenden pulvermischung | |
DE20321314U1 (de) | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung | |
WO2014102253A1 (de) | Monolithische arzneiform zur modifizierten freisetzung einer wirkstoffkombination | |
DE19800927A1 (de) | Verfahren zur Herstellung von festen Dosierungsformen | |
WO1997015291A1 (de) | Verfahren zur herstellung von festen arzneiformen | |
DE2424950A1 (de) | Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung | |
EP2303239A1 (de) | Direktverpresste aliskiren-tabletten | |
EP0859602A1 (de) | Verfahren zur herstellung von festen arzneiformen | |
Sharma et al. | Comparison Effect of Natural and Synthetic Superdisintigrants In Fast Dissolving Tablet Formulation | |
KR20050016465A (ko) | 활성 물질을 지속 방출시키는 약제학적 조성물 및 이의제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003735396 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2485080 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/011813 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 374041 Country of ref document: PL Ref document number: 2004508786 Country of ref document: JP Ref document number: 1020047019283 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1020047019283 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003735396 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10516268 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003735396 Country of ref document: EP |